A detailed history of Polar Capital Holdings PLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 3,500,000 shares of ROIV stock, worth $41.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,500,000
Previous 1,500,000 133.33%
Holding current value
$41.9 Million
Previous $15.9 Million 154.75%
% of portfolio
0.25%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.17 - $12.5 $20.3 Million - $25 Million
2,000,000 Added 133.33%
3,500,000 $40.4 Million
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $14.8 Million - $17.7 Million
1,500,000 New
1,500,000 $15.8 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.43B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.